Abstract:Background: The role of purinergic P2X7 receptor (P2X7R) is of interest due to its involvement in inflammation and mediating immune cell responses. P2X7R is particularly implicated in the development of inflammatory bowel disease (IBD). However, the extent of the actions of P2X7R in the gastrointestinal (GI) system under physiological and pathophysiological conditions remains to be elucidated. This systematic review aimed to identify, summarize and evaluate the evidence for a critical role of P2X7R in the GI system. Methods: We searched PubMed, Embase and Scopus with search terms pertained to P2X7R in the GI system in disease or physiological state, including “P2X7 or P2X7 receptor or purinergic signaling” in combination with any of the terms “intestine or colon or gut or gastrointestinal,” “pathology or inflammation or disease or disorder,” and “physiology or expression.” Titles and abstracts were screened for potentially eligible full texts, and animal and human studies published in English were included in this study. Data were extracted from papers meeting inclusion criteria. Meta-analysis was not feasible given the study diversity. Results: There were 48 papers included in this review. We identified 14 experimental colitis models, three sepsis models and one ischemia-reperfusion injury model. Among them, 11 studies examined P2X7R in GI infections, six studies on immune cell regulation, four studies on GI inflammation, two studies on GI malignancies, three studies involving intestinal injury due to various causes, two studies on ATP-activated P2X7R in the GI system and two studies on metabolic regulation. Conclusion: Evidence supports P2X7R mediating inflammation and immune cell responses in GI inflammation, infections and injury due to IBD and other challenges to the intestinal wall. P2X7R inhibition by gene knockout or by application of P2X7R antagonists can reduce tissue damage by suppressing inflammation. P2X7R is also implicated in GI malignancies and glucose and lipid homeostasis. P2X7R blockade, however, did not always lead to beneficial outcomes in the various pathological models of study.

Research Progress of P2X7 Receptor in Inflammatory Bowel Disease

Research progress of P2X7 receptor in inflammatory bowel disease.

Research Progress of Phosphodiesterase Inhibitors in Inflammatory Bowel Disease Treatment.

Pathophysiological Role of Purinergic P2X Receptors in Digestive System Diseases

Understanding the Role of Purinergic P2X7 Receptors in the Gastrointestinal System: A Systematic Review

[Effect of P2X7 Receptor on Inflammatory Diseases and Its Mechanism].

Progress in the Relationship Between P2X7R and Colorectal Cancer

P2 X7 receptor and renal diseases

P2X7 receptor: A potential therapeutic target for autoimmune diseases

Progress of P2X7 Receptor Research in Chronic Pain

Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists

Extracellular ATP Mediates Inflammatory Responses in Colitis Via P2 × 7 Receptor Signaling

Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine

P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease

Regulation of Immune Response by P2X7 Receptor.

Targeting Purinergic Receptor P2RX1 Modulates Intestinal Microbiota and Alleviates Inflammation in Colitis

The P2X7 Purinergic Receptor: an Emerging Therapeutic Target in Cardiovascular Diseases

The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications

Critical Roles of G Protein-Coupled Receptors in Regulating Intestinal Homeostasis and Inflammatory Bowel Disease

Research Progress on the P2X7 Receptor in Liver Injury and Hepatocellular Carcinoma

Potential roles and therapeutic applications of P2 X7 receptor in inflammation and pain